This inventor holds 2 USPTO granted patents. Top assignee: Ube Industries, Inc.. Active years: 1990-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1993
Title: Kayoko Yamano: Innovator in Pharmaceutical Chemistry
Introduction
Kayoko Yamano is a prominent inventor based in Ube, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents to her name, her work has garnered attention in the scientific community.
Latest Patents
Yamano's latest patents include innovative compounds that have potential pharmaceutical applications. One of her notable inventions is a diarylmethoxypiperidine derivative, which is represented by a specific formula. This compound features phenyl or pyridyl groups and has been designed to have various substituents, making it a versatile candidate for further research. Additionally, she has developed piperidine and piperazine derivatives that exhibit antihistaminic and antiallergic effects. These compounds are not only significant in their chemical structure but also in their potential therapeutic benefits.
Career Highlights
Kayoko Yamano is associated with Ube Industries, Inc., where she has been instrumental in advancing research in pharmaceutical chemistry. Her work has led to the development of compounds that could improve treatment options for various allergic conditions. Her dedication to innovation in this field has established her as a key figure in her company.
Collaborations
Yamano collaborates with esteemed colleagues such as Shinji Takamura and Hiroshi Fujiwara. These partnerships enhance her research efforts and contribute to the successful development of her patented compounds.
Conclusion
Kayoko Yamano's contributions to pharmaceutical chemistry through her innovative patents highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
